http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03135976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c8bffd30b513a7c8ac7d736fa3ef27f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D327-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/F24F-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D327-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E04D-
filingDate 1989-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdae9e0e5b25d6d98f52cb59fec5541
publicationDate 1991-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03135976-A
titleOfInvention Cyclic ether derivatives, their production, and 5-lipoxygenas inhibitory agent
abstract NEW MATERIAL: A compound of formula I [Ar 1 is optionally substd. phenyl or naphthyl; A 1 is C 1-6 alkylene, C 3-6 alkenylene, etc.; Ar 2 is phenylene or 6-membered heterocycle; R 1 and R 2 together form -A 2 -X-A 3 - (A 2 and A 3 are each C 1-6 alkylene; X is oxy, thio, etc.); R 3 is C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, etc.], and its salt. n EXAMPLE: 4-ethyl-2,2-dimethyl-4-[3-(napht-2-ylmethoxy)phenyl]-1,3-dioxolane. n USE: Inhibitors of the enzyme 5-lipoxygenase and useful for asthma symptomatic allergy, allergic rhinititis, psoriasis, atopic skin disease, etc. n PROCESS: A compound of formula II is alkylated with a compound of the formula A 1 -A 1 -Z (Z is a removable group) and the protecting group is optionally removed to give the compound of formula I. n COPYRIGHT: (C)1991,JPO
priorityDate 1988-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19756606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456357891
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12527
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48999
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MQ78
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404074
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8R1G6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25290
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID573013
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID477753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234777440
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QV45
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11689
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCK7GQZ4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PRG7

Total number of triples: 53.